Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Voyager Therapeutics Inc shares valued at $36,643 were sold by Jorgensen Nathan D. on Oct 03 ’25. At $4.78 per share, Jorgensen Nathan D. sold 7,666 shares. The insider’s holdings dropped to 123,834 shares worth approximately $0.64 million following the completion of this transaction.
Also, Fahey Sandell Jacquelyn purchased 5,843 shares, netting a total of over 27,937 in proceeds.
Before that, Jorgensen Nathan D. had added 7,666 shares to its account. In a trade valued at $36,634, the Officer bought Voyager Therapeutics Inc shares for $4.78 each.
As published in their initiating research note from Cantor Fitzgerald on January 10, 2025, Voyager Therapeutics Inc [VYGR] has been an Overweight. Analysts at Citigroup started covering the stock with ‘”a Buy”‘ outlook in a report released in early December. Earlier on October 16, 2024, Leerink Partners initiated its rating. Their recommendation was “an Outperform” for VYGR stock.
Analyzing VYGR Stock Performance
On last trading session, Voyager Therapeutics Inc [NASDAQ: VYGR] plunged -2.46% to $5.15. The stock’s lowest price that day was $5.05, but it reached a high of $5.55 in the same session. During the last five days, there has been a surge of approximately 9.11%. Over the course of the year, Voyager Therapeutics Inc shares have dropped approximately -24.15%. Shares of the company reached a 52-week high of $6.27 on 01/07/25 and a 52-week low of $2.64 on 05/30/25.
Support And Resistance Levels for Voyager Therapeutics Inc (VYGR)
According to the 24-hour chart, there is a support level at 4.95, which, if violated, would cause prices to drop to 4.75. In the upper region, resistance lies at 5.45. The next price resistance is at 5.75. RSI (Relative Strength Index) is 66.82 on the 14-day chart, showing neutral technical sentiment.
Is Voyager Therapeutics Inc subject to short interest?
Stocks of Voyager Therapeutics Inc saw a sharp rise in short interest on 2025-09-15 jumping by 0.17 million shares to 3.14 million. Data from Yahoo Finance shows that the short interest on 2025-08-15 was 2.97 million shares. A jump of 5.34% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 4.79 of the overall float, the days-to-cover ratio (short ratio) jumped to 4.79.
Which companies own the most shares of Voyager Therapeutics Inc (VYGR)?
In terms of Voyager Therapeutics Inc share price expectations, FactSet research, analysts set an average price target of 18 in the next 12 months, up nearly 240.91% from the previous closing price of $5.28. Analysts anticipate Voyager Therapeutics Inc stock to reach 18 by 2025, with the lowest price target being 8. In spite of this, 2 analysts ranked Voyager Therapeutics Inc stock as Buy at the end of 2025. On March 26, 2024, Guggenheim assigned a price target of “a Buy” to the stock and initiated coverage with a $22.
